Update in Papillary Thyroid Cancer - 26/07/25
Doi : 10.1016/j.ecl.2025.03.007
William Kuenstner, MD ⁎ 
, Yazan Alzedaneen, MD, Kenneth D. Burman, MD
, Yazan Alzedaneen, MD, Kenneth D. Burman, MD Division of Endocrinology, Department of Medicine, MedStar Washington Hospital Center, Washington, DC, USA
∗Corresponding author. 3800 Reservoir Road Northwest, Washington, DC 20007-2113.3800 Reservoir Road NorthwestWashingtonDC20007-2113
Riassunto |
Our article discusses the latest updates in controversies surrounding differentiated thyroid cancer, focusing on: active surveillance of low-risk differentiated thyroid cancer, thyroid lobectomy as initial surgical management, long-term surveillance of differentiated thyroid cancer, and TSH suppression goals and rationale postoperatively.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Differentiated thyroid cancer, Active surveillance, Thyroid lobectomy, Total thyroidectomy, Serum thyroglobulin, Thyroid cancer surveillance, TSH suppression
Mappa
© 2025
Elsevier Inc. Tutti i diritti riservati.
Vol 54 - N° 3
P. 329-340 - settembre 2025 Ritorno al numero
Articolo precedente
- Thyroid Cancer: An Update in Causal Mechanisms, Diagnosis, Initial Treatment, and Long-Term Management
- Kenneth D. Burman, Jacqueline Jonklaas
- Advances in Follicular Thyroid Cancer Diagnosis and Management
- Benjamin J. Gigliotti, Anna-Karoline Israel, Timothy B. Winslow, Alessandra Moore
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?